Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
MedSIR
City of Hope Medical Center
Stanford University
Big Ten Cancer Research Consortium
MedSIR
Dana-Farber Cancer Institute
Medical College of Wisconsin
University of Pittsburgh
Karolinska Institutet
Emory University
Northwestern University
GOG Foundation
Johns Hopkins University
AC Camargo Cancer Center
Palleos Healthcare GmbH
University of Nebraska
ARCAGY/ GINECO GROUP
ARCAGY/ GINECO GROUP
Eastern Cooperative Oncology Group
CHU de Quebec-Universite Laval
University of California, San Francisco
University of Colorado, Denver
Baylor College of Medicine
The Methodist Hospital Research Institute
Institut Cancerologie de l'Ouest
Baylor College of Medicine
Radiation Therapy Oncology Group
Institut de Cancérologie de Lorraine
Children's Oncology Group
SCRI Development Innovations, LLC
University of Alabama at Birmingham
National Cancer Institute (NCI)
Evgen Pharma
Mansoura University
SOLTI Breast Cancer Research Group
University of Utah
Eli Lilly and Company
University Hospital, Essen
University of Washington
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt University
Alliance for Clinical Trials in Oncology
National Institutes of Health Clinical Center (CC)
AstraZeneca
Northwestern University
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California